These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19139310)

  • 21. ALS-Plus syndrome: non-pyramidal features in a large ALS cohort.
    McCluskey L; Vandriel S; Elman L; Van Deerlin VM; Powers J; Boller A; Wood EM; Woo J; McMillan CT; Rascovsky K; Grossman M
    J Neurol Sci; 2014 Oct; 345(1-2):118-24. PubMed ID: 25086858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progress in clinical neurosciences: Frontotemporal dementia-pick's disease.
    Kertesz A
    Can J Neurol Sci; 2006 May; 33(2):141-8. PubMed ID: 16736722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis.
    Blair IP; Williams KL; Warraich ST; Durnall JC; Thoeng AD; Manavis J; Blumbergs PC; Vucic S; Kiernan MC; Nicholson GA
    J Neurol Neurosurg Psychiatry; 2010 Jun; 81(6):639-45. PubMed ID: 19965854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
    Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
    Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis.
    Van Deerlin VM; Leverenz JB; Bekris LM; Bird TD; Yuan W; Elman LB; Clay D; Wood EM; Chen-Plotkin AS; Martinez-Lage M; Steinbart E; McCluskey L; Grossman M; Neumann M; Wu IL; Yang WS; Kalb R; Galasko DR; Montine TJ; Trojanowski JQ; Lee VM; Schellenberg GD; Yu CE
    Lancet Neurol; 2008 May; 7(5):409-16. PubMed ID: 18396105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies.
    Uryu K; Nakashima-Yasuda H; Forman MS; Kwong LK; Clark CM; Grossman M; Miller BL; Kretzschmar HA; Lee VM; Trojanowski JQ; Neumann M
    J Neuropathol Exp Neurol; 2008 Jun; 67(6):555-64. PubMed ID: 18520774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathologic features of autosomal recessive amyotrophic lateral sclerosis associated with optineurin mutation.
    Kamada M; Izumi Y; Ayaki T; Nakamura M; Kagawa S; Kudo E; Sako W; Maruyama H; Nishida Y; Kawakami H; Ito H; Kaji R
    Neuropathology; 2014 Feb; 34(1):64-70. PubMed ID: 23889540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam.
    Geser F; Winton MJ; Kwong LK; Xu Y; Xie SX; Igaz LM; Garruto RM; Perl DP; Galasko D; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2008 Jan; 115(1):133-45. PubMed ID: 17713769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enduring involvement of tau, beta-amyloid, alpha-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam (ALS/PDC).
    Miklossy J; Steele JC; Yu S; McCall S; Sandberg G; McGeer EG; McGeer PL
    Acta Neuropathol; 2008 Dec; 116(6):625-37. PubMed ID: 18843496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occurrence of eye movement disorders in motor neuron disease.
    Beaufils E; Corcia P; de Toffol B; Praline J
    Amyotroph Lateral Scler; 2012 Jan; 13(1):84-6. PubMed ID: 22117133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype.
    Mann DMA; Snowden JS
    Brain Pathol; 2017 Nov; 27(6):723-736. PubMed ID: 28100023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic analysis of matrin 3 gene in French amyotrophic lateral sclerosis patients and frontotemporal lobar degeneration with amyotrophic lateral sclerosis patients.
    Millecamps S; De Septenville A; Teyssou E; Daniau M; Camuzat A; Albert M; LeGuern E; Galimberti D; ; Brice A; Marie Y; Le Ber I
    Neurobiol Aging; 2014 Dec; 35(12):2882.e13-2882.e15. PubMed ID: 25158920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A fatal neuromuscular disease in an adult patient after poliomyelitis in early childhood: consideration of the pathology of post-polio syndrome.
    Kosaka T; Kuroha Y; Tada M; Hasegawa A; Tani T; Matsubara N; Koike R; Toyoshima Y; Takahashi H
    Neuropathology; 2013 Feb; 33(1):93-101. PubMed ID: 22672529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary lateral sclerosis as a phenotypic manifestation of familial ALS.
    Brugman F; Wokke JH; Vianney de Jong JM; Franssen H; Faber CG; Van den Berg LH
    Neurology; 2005 May; 64(10):1778-9. PubMed ID: 15911810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Significance of TDP-43 Neuropathology in Amyotrophic Lateral Sclerosis.
    Cykowski MD; Powell SZ; Peterson LE; Appel JW; Rivera AL; Takei H; Chang E; Appel SH
    J Neuropathol Exp Neurol; 2017 May; 76(5):402-413. PubMed ID: 28521037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS.
    Robertson J; Sanelli T; Xiao S; Yang W; Horne P; Hammond R; Pioro EP; Strong MJ
    Neurosci Lett; 2007 Jun; 420(2):128-32. PubMed ID: 17543992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea.
    Kovacs GG; Murrell JR; Horvath S; Haraszti L; Majtenyi K; Molnar MJ; Budka H; Ghetti B; Spina S
    Mov Disord; 2009 Sep; 24(12):1843-7. PubMed ID: 19609911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progressive supranuclear palsy presenting as primary lateral sclerosis but lacking parkinsonism, gaze palsy, aphasia, or dementia.
    Nagao S; Yokota O; Nanba R; Takata H; Haraguchi T; Ishizu H; Ikeda C; Takeda N; Oshima E; Sakane K; Terada S; Ihara Y; Uchitomi Y
    J Neurol Sci; 2012 Dec; 323(1-2):147-53. PubMed ID: 23026537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frontotemporal and motor neurone degeneration with neurofilament inclusion bodies: additional evidence for overlap between FTD and ALS.
    Bigio EH; Lipton AM; White CL; Dickson DW; Hirano A
    Neuropathol Appl Neurobiol; 2003 Jun; 29(3):239-53. PubMed ID: 12787321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transportin 1 accumulates specifically with FET proteins but no other transportin cargos in FTLD-FUS and is absent in FUS inclusions in ALS with FUS mutations.
    Neumann M; Valori CF; Ansorge O; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ishihara K; Ang LC; Bilbao JM; Mackenzie IR
    Acta Neuropathol; 2012 Nov; 124(5):705-16. PubMed ID: 22842875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.